Nasdaq Delists Ace Global Business Acquisition  

Ace Global Business Acquisition in an 8-K said its stock will be delisted from the Nasdaq on May 24 due to non-compliance with a listing rule that a SPAC must complete a merger within 36 months of its IPO registration.

Although Ace Global had requested a hearing on the matter, the SPAC said it withdrew the request.

The SPAC did not disclose its next move.

Ace Global has a deal pending with LE Worldwide. The target produces Light-Emitting Diode technology, with one of the largest LED product manufacturing and research facilities in Asia.

The SPAC in September reduced the merger consideration from $150 million to $110 million.

Ace Global lost nearly half of its cash in trust to redemptions ahead of an extension vote in January 2023. The SPAC raised about $46 million in an IPO more than three years ago. Read more.

Total
0
Shares
Related Posts
Read More

Phoenix Biotech Receives Nasdaq Warning

Phoenix in June signed a merger agreement with CERo Therapeutics at a pro forma equity capitalization of $145 million. The target is an immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms.